Literature DB >> 24402990

Vitamin D and prostate cancer survival in veterans.

Tatyana Der1, Beth A Bailey2, Dima Youssef1, Todd Manning3, William B Grant4, Alan N Peiris1.   

Abstract

Prostate cancer remains the second most commonly diagnosed cancer among the male population worldwide. Vitamin D deficiency has been linked to prostate cancer and its aggressiveness. Herein, we initiated a retrospective study to evaluate vitamin D status and monitoring in veterans with prostate cancer, and to examine the potential link between vitamin D and survival status and length of survival in this population. We found that veterans who were initially vitamin D deficient were significantly less likely to survive than those who were not initially deficient, and that both initial and follow-up vitamin D deficiency were associated with decreased likelihood of survival after prostate cancer diagnosis. We recommend that vitamin D deficiency be replaced in veterans with prostate cancer. Reprint &
Copyright © 2014 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402990     DOI: 10.7205/MILMED-D-12-00540

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  9 in total

1.  Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms.

Authors:  Chuck C Blajszczak; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2019-09-28       Impact factor: 4.292

Review 2.  Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits.

Authors:  William B Grant; Fatme Al Anouti; Meis Moukayed
Journal:  Eur J Clin Nutr       Date:  2020-01-29       Impact factor: 4.016

3.  Low vitamin D levels are associated with higher opioid dose in palliative cancer patients--results from an observational study in Sweden.

Authors:  Peter Bergman; Susanne Sperneder; Jonas Höijer; Jenny Bergqvist; Linda Björkhem-Bergman
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 4.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis.

Authors:  P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

5.  Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels.

Authors:  Anna Markiewicz; Anna A Brożyna; Ewa Podgórska; Martyna Elas; Krystyna Urbańska; Anton M Jetten; Andrzej T Slominski; Wojciech Jóźwicki; Jolanta Orłowska-Heitzman; Grzegorz Dyduch; Bożena Romanowska-Dixon
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

6.  Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men.

Authors:  Donovan McGrowder; Marshall K Tulloch-Reid; Kathleen C M Coard; Afette M McCaw-Binns; Trevor S Ferguson; William Aiken; Leroy Harrison; Simon G Anderson; Maria D Jackson
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

Review 7.  Vitamin D in Pain Management.

Authors:  Maria Helde-Frankling; Linda Björkhem-Bergman
Journal:  Int J Mol Sci       Date:  2017-10-18       Impact factor: 5.923

8.  Differences in discontinuation of statin treatment in women and men with advanced cancer disease.

Authors:  Helena Bergström; Elsa Brånvall; Maria Helde-Frankling; Linda Björkhem-Bergman
Journal:  Biol Sex Differ       Date:  2018-10-20       Impact factor: 5.027

Review 9.  Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis.

Authors:  Zhen-Yu Song; Qiuming Yao; Zhiyuan Zhuo; Zhe Ma; Gang Chen
Journal:  Endocr Connect       Date:  2018-12-01       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.